Literature DB >> 22571104

Introducing misoprostol for the treatment of incomplete abortion in Nigeria.

Talemoh Dah1, Akinsewa Akiode, Paschal Awah, Tamara Fetters, Mathew Okoh, Innocent Ujah, Ejike Oji.   

Abstract

Despite legal restriction, induced abortions and resulting complications are common in Nigeria. Misoprostol administration for incomplete abortion was introduced in 3 Nigerian hospitals. The feasibility of the hospitals, patient and provider acceptability were assessed using questionnaire and interview guides administered to 205 women and 17 providers respectively. Amongst the women, 194 (95%) were satisfied and very satisfied with misoprostol, 176 (86%) would choose misoprostol again if another incomplete abortion occurred and 191 (93%) would recommend it to another woman in a similar situation. Providers were highly satisfied with misoprostol. The ease of use and ability to redirect surgical resources to more complicated issues were positive features cited by them. The providers agreed that integration of misoprostol was straightforward and required few resources. Therefore, misoprostol for incomplete abortion is safe, efficacious and acceptable to providers and patients. In remote areas of Nigeria with limited post-abortion care (PAC), misoprostol administration is an important potential PAC treatment modality. Features of misoprostol-low cost, room temperature stability, and ease of introduction-render it an important treatment option, particularly in low resource and rural settings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22571104

Source DB:  PubMed          Journal:  Afr J Reprod Health        ISSN: 1118-4841


  8 in total

1.  Exploring health care providers' experiences of and perceptions towards the use of misoprostol for management of second trimester incomplete abortion in Central Uganda.

Authors:  Susan Atuhairwe; Kristina Gemzell-Danielsson; Lynn Atuyambe; Josaphat Byamugisha; Nazarius Mbona Tumwesigye; Claudia Hanson
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

2.  Barriers and facilitators in the provision of post-abortion care at district level in central Uganda - a qualitative study focusing on task sharing between physicians and midwives.

Authors:  Mandira Paul; Kristina Gemzell-Danielsson; Charles Kiggundu; Rebecka Namugenyi; Marie Klingberg-Allvin
Journal:  BMC Health Serv Res       Date:  2014-01-21       Impact factor: 2.655

3.  Women's Acceptability of Misoprostol Treatment for Incomplete Abortion by Midwives and Physicians - Secondary Outcome Analysis from a Randomized Controlled Equivalence Trial at District Level in Uganda.

Authors:  Amanda Cleeve; Josaphat Byamugisha; Kristina Gemzell-Danielsson; Nazarius Mbona Tumwesigye; Susan Atuhairwe; Elisabeth Faxelid; Marie Klingberg-Allvin
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

4.  Sublingual misoprostol versus manual vacuum aspiration for treatment of incomplete abortion in Nigeria: a randomized control study.

Authors:  Vincent Chinedu Ani; Joseph Tochukwu Enebe; Cyril Chukwudi Dim; Ngozi Regina Dim; Benjamin Chukwuma Ozumba
Journal:  Pan Afr Med J       Date:  2022-02-01

5.  Implementation of misoprostol for postabortion care in Kenya and Uganda: a qualitative evaluation.

Authors:  Joachim Osur; Traci L Baird; Brooke A Levandowski; Emily Jackson; Daniel Murokora
Journal:  Glob Health Action       Date:  2013-04-24       Impact factor: 2.640

6.  Letter to the editor.

Authors:  Joachim Osur; Traci L Baird; Brooke A Levandowski; Emily Jackson; Daniel Murokora
Journal:  Glob Health Action       Date:  2013-07-18       Impact factor: 2.640

Review 7.  Postabortion Care: 20 Years of Strong Evidence on Emergency Treatment, Family Planning, and Other Programming Components.

Authors:  Douglas Huber; Carolyn Curtis; Laili Irani; Sara Pappa; Lauren Arrington
Journal:  Glob Health Sci Pract       Date:  2016-09-29

8.  Trends in misoprostol use and abortion complications: A cross-sectional study from nine referral hospitals in Nigeria.

Authors:  Folasade Adenike Bello; Bukola Fawole; Babawale Oluborode; Ibraheem Awowole; Theresa Irinyenikan; David Awonuga; Olabisi Loto; Adetokunbo Fabamwo; Philip Guest; Bela Ganatra
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.